Dr. Thomas Anderson Smith, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 186 Hospital Rd, Ste 300, Winchester, TN 37398 Phone: 931-967-9680 Fax: 931-967-7362 |
Dr. Sherri Lee Walker, D. O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1383 S College St, Ste. 2, Winchester, TN 37398 Phone: 931-810-8012 Fax: 931-241-6630 |
Dr. Shon Patrick Nolin, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1894 Cowan Hwy, Suite 2, Winchester, TN 37398 Phone: 931-962-4040 Fax: 931-962-2277 |
Mrs. Nancy Yoakum Blevins, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 155 Hospital Rd, Ste #a, Winchester, TN 37398 Phone: 931-962-2229 Fax: 931-967-8918 |
Terry Scott Holder, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 155 Hospital Rd, Ste #a, Winchester, TN 37398 Phone: 931-962-2229 Fax: 931-967-8918 |
Mr. Kou Wei Chiu, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2020 Cowan Hwy, Ste 2, Winchester, TN 37398 Phone: 931-361-0100 Fax: 931-962-8856 |
News Archive
The U.S. Food and Drug Administration today expanded the approval of Zelboraf (vemurafenib) to include the treatment of certain adult patients with Erdheim-Chester Disease (ECD), a rare cancer of the blood.
Commercially prepared baby foods that purport to be loaded with dark green vegetables are sweetened with fruit puree and often don't contain a high percentage of dark green vegetable content, according to a team of researchers.
Halt Medical is very pleased to announce that the American Medical Association Current Procedure Terminology Panel has established a new CPT code specifically for Radiofrequency Ablation of Uterine Fibroids.
Engineered strands of DNA - nanoscale tools called "nanoswitches" - could be the key to faster, easier, cheaper and more sensitive tests that can enable high-fidelity detection of biomarkers indicating the presence of different diseases, viral strains and even genetic variabilities as subtle as a single-gene mutation.
Regado Biosciences, a privately held company leading the development of antithrombotic aptamers with active control agents, announced today that the European Patent Office (EPO) has notified the Company of its intent to grant a patent with claims directed to oligonucleotide modulators of blood coagulation factor aptamers in EP 1401853. This new patent grant in the Company's portfolio extends the scope and breadth of Regado's intellectual property estate.
› Verified 4 days ago